B A Teicher

1.1k total citations
11 papers, 902 citations indexed

About

B A Teicher is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, B A Teicher has authored 11 papers receiving a total of 902 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in B A Teicher's work include Cancer, Hypoxia, and Metabolism (5 papers), Cancer therapeutics and mechanisms (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). B A Teicher is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Cancer therapeutics and mechanisms (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). B A Teicher collaborates with scholars based in United States. B A Teicher's co-authors include Vito J. Palombella, Roy S. Herbst, Julian Adams, E Frei, Yan Wang, Sylvia A. Holden, Kathleen N. S. Cathcart, Andrew Docherty, Margaret A. Shipp and Ian C. Anderson and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, International Journal of Radiation Oncology*Biology*Physics and International Journal of Cancer.

In The Last Decade

B A Teicher

11 papers receiving 868 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B A Teicher United States	11	588	407	249	136	76	11	902
B Soehnlen United States	11	582 1.0×	513 1.3×	188 0.8×	269 2.0×	139 1.8×	15	1.2k
Joseph J. Catino United Kingdom	12	887 1.5×	517 1.3×	121 0.5×	64 0.5×	66 0.9×	14	1.2k
Marie Regairaz France	13	897 1.5×	495 1.2×	150 0.6×	81 0.6×	61 0.8×	15	1.2k
B Forseth United States	13	404 0.7×	200 0.5×	251 1.0×	48 0.4×	55 0.7×	18	676
Yoshihiro Mitsuhashi Japan	10	866 1.5×	455 1.1×	409 1.6×	56 0.4×	130 1.7×	11	1.2k
Julie A. Losman United States	11	634 1.1×	516 1.3×	451 1.8×	128 0.9×	44 0.6×	11	1.4k
Vernon T. Phan United States	12	583 1.0×	252 0.6×	164 0.7×	202 1.5×	117 1.5×	16	875
W. E. Berdel Germany	19	546 0.9×	445 1.1×	126 0.5×	383 2.8×	93 1.2×	49	1.3k
M Jacrot France	15	376 0.6×	378 0.9×	77 0.3×	103 0.8×	109 1.4×	31	796
Haiyun Cheng United States	9	568 1.0×	472 1.2×	193 0.8×	73 0.5×	73 1.0×	12	944

Countries citing papers authored by B A Teicher

Since Specialization

Citations

This map shows the geographic impact of B A Teicher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B A Teicher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B A Teicher more than expected).

Fields of papers citing papers by B A Teicher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B A Teicher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B A Teicher. The network helps show where B A Teicher may publish in the future.

Co-authorship network of co-authors of B A Teicher

This figure shows the co-authorship network connecting the top 25 collaborators of B A Teicher. A scholar is included among the top collaborators of B A Teicher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B A Teicher. B A Teicher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Menon, Krishna, et al.. (2000). Antitumor activity of cryptophycins: effect of infusion time and combination studies. Cancer Chemotherapy and Pharmacology. 46(2). 142–149. 24 indexed citations

Teicher, B A, et al.. (1999). The proteasome inhibitor PS-341 in cancer therapy.. PubMed. 5(9). 2638–45. 397 indexed citations

Teicher, B A, et al.. (1998). Optimal scheduling of interleukin-12 and fractionated radiation therapy in the murine lewis lung carcinoma. Radiation Oncology Investigations. 6(2). 71–80. 17 indexed citations

Kakeji, Yoshihiro, Yoshihiko Maehara, Masahiko Ikebe, & B A Teicher. (1997). Dynamics of tumor oxygenation, CD31 staining and transforming growth factor-β levels after treatment with radiation or cyclophosphamide in the rat 13762 mammary carcinoma. International Journal of Radiation Oncology*Biology*Physics. 37(5). 1115–1123. 42 indexed citations

Anderson, Ian C., Margaret A. Shipp, Andrew Docherty, & B A Teicher. (1996). Combination therapy including a gelatinase inhibitor and cytotoxic agent reduces local invasion and metastasis of murine Lewis lung carcinoma.. PubMed. 56(4). 715–8. 81 indexed citations

Teicher, B A. (1995). Angiogenesis and cancer metastases: therapeutic approaches. Critical Reviews in Oncology/Hematology. 20(1-2). 9–39. 32 indexed citations

Korbut, Timothy, et al.. (1993). Interaction of topoisomerase I inhibitors with radiation in cis‐diamminedichloroplatinum(II)‐sensitive and ‐resistantcells In Vitro and in the fsaiic fibrosarcoma In Vivo. International Journal of Cancer. 53(1). 118–123. 45 indexed citations

Teicher, B A, et al.. (1991). Lonidamine as a modulator of alkylating agent activity in vitro and in vivo.. PubMed. 51(3). 780–4. 35 indexed citations

Teicher, B A, et al.. (1989). Optimization of perfluorochemical levels with radiation therapy in mice.. PubMed. 49(10). 2693–7. 37 indexed citations

10.

Frei, E, B A Teicher, Sylvia A. Holden, Kathleen N. S. Cathcart, & Yan Wang. (1988). Preclinical studies and clinical correlation of the effect of alkylating dose.. PubMed. 48(22). 6417–23. 158 indexed citations

11.

Teicher, B A, et al.. (1985). Effect of Oxygen on the Cytotoxicity and Antitumor Activity of Etoposide<xref ref-type="fn" rid="FN2">2</xref>. JNCI Journal of the National Cancer Institute. 75(6). 1129–33. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact